https://cofacto.ai/market-news/sigmaadv-q2-fy27-earnings-call Cofacto en 2026-11-10T12:24:13.720311+00:00 Sigma Advanced System Ltd (SIGMAADV) Q2 FY27 Earnings Call: Order Book Crosses Rs. 10,000 Cr, Targets Rs. 2,000 Cr FY27 Revenue https://cofacto.ai/market-news/utlsolar-q2-fy27-earnings-call Cofacto en 2026-11-10T10:23:35.411794+00:00 Fujiyama Power Systems Ltd (UTLSOLAR) Q2 FY27 Earnings Call: Revenue Up 130% YoY, Holds 70% Growth Guidance https://cofacto.ai/market-news/whirlpool-q2-fy27-results-analysis Cofacto en 2026-11-09T11:45:32.845932+00:00 Whirlpool of India Q2 FY27 Results Analysis: PAT Plunges 39%, Record Revenue Rises 13.7% https://cofacto.ai/market-news/nuvama-q2-fy27-earnings-call Cofacto en 2026-11-09T11:15:32.792024+00:00 Nuvama Wealth Q2 FY27 Earnings Call: Record Net New Money Across Wealth Arms, H1 Dividend Withheld https://cofacto.ai/market-news/gland-q2-fy27-earnings-call Cofacto en 2026-11-09T09:43:37.038921+00:00 Gland Pharma Ltd Q2 FY27 Earnings Call: Approves Rs. 1,000 Cr Brownfield Capex, PAT Surges 58% YoY https://cofacto.ai/market-news/icil-q2-fy27-earnings-call Cofacto en 2026-11-08T12:40:35.003012+00:00 Indo Count Industries Ltd (ICIL) Q2 FY27 Earnings Call: To Exceed Rs. 5,500 Cr Revenue Guidance, Reaffirms Rs. 8,000 Cr CY28 Target https://cofacto.ai/market-news/symbiotec-q2-fy27-results-analysis Cofacto en 2026-11-08T12:39:53.436643+00:00 Symbiotec Pharmalab Ltd Q2 FY27 Results Analysis: Revenue Jumps 43%, EBITDA Margin Rebounds https://cofacto.ai/market-news/symbiotec-q2-fy27-earnings-call Cofacto en 2026-11-08T12:39:46.287780+00:00 Symbiotec Pharmalab Q2 FY27 Earnings Call: Rs. 53 Cr Milestone Lifts Revenue 43%, Europe Deal Expands Capacity to 750 KL